Investing Ideas
/
Australian Pharmaceuticals & Biotech Precious Metals

Header cover image

Australian Pharmaceuticals & Biotech Precious Metals

UPDATED Apr 09, 2024

Gold, Silver and Precious Metals companies ordered by Snowflake size.

12 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	NEU Neuren Pharmaceuticals	AU$20.49	0.4%	55.8%	AU$2.6b	AU$26.74	PE16.7x	E5.2%	n/a
	TLX Telix Pharmaceuticals	AU$12.38	3.2%	66.6%	AU$4.0b	AU$14.88	PE771.6x	E37.9%	n/a
	ARX Aroa Biosurgery	AU$0.57	5.5%	-45.0%	AU$197.9m	AU$1.02	PS3.3x	E115.3%	n/a
	ACR Acrux	AU$0.065	1.6%	27.5%	AU$18.9m	n/a	PS1.7x	E115.3%	0%
	IMM Immutep	AU$0.39	0%	62.5%	AU$463.6m	AU$1.30	PS117.9x	E60.3%	n/a
	MSB Mesoblast	AU$0.88	-0.6%	-12.4%	AU$1.0b	AU$1.10	PS89x	E64.4%	n/a
	TRJ Trajan Group Holdings	AU$1.29	15.2%	-25.4%	AU$196.4m	AU$1.80	PS1.2x	E85.4%	n/a
	MYX Mayne Pharma Group	AU$7.19	1.4%	75.4%	AU$583.5m	AU$7.04	PS1.8x	E110.2%	n/a
	CSL CSL	AU$283.37	0.4%	-6.8%	AU$136.9b	AU$301.29	PE36.7x	E14.8%	1.3%
	KZA Kazia Therapeutics	AU$0.08	-27.3%	-17.5%	AU$18.9m	n/a	PS34068.4x	E49.6%	n/a
	PAR Paradigm Biopharmaceuticals	AU$0.30	-11.6%	-73.5%	AU$107.0m	AU$2.30	PS2545.5x	E105.3%	n/a
	IMU Imugene	AU$0.10	-4.8%	-23.1%	AU$732.0m	n/a	PS48.7x	E52.5%	n/a

Page 1 of 1